GOVX
Price
$2.67
Change
+$0.09 (+3.49%)
Updated
Feb 6 closing price
Capitalization
4.64M
Intraday BUY SELL Signals
STRO
Price
$15.52
Change
+$0.92 (+6.30%)
Updated
Feb 6 closing price
Capitalization
131.54M
32 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

GOVX vs STRO

Header iconGOVX vs STRO Comparison
Open Charts GOVX vs STROBanner chart's image
GeoVax Labs
Price$2.67
Change+$0.09 (+3.49%)
Volume$67.36K
Capitalization4.64M
Sutro Biopharma
Price$15.52
Change+$0.92 (+6.30%)
Volume$108.98K
Capitalization131.54M
GOVX vs STRO Comparison Chart in %
GOVX
Daily Signal:
Gain/Loss:
STRO
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
GOVX vs. STRO commentary
Feb 09, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GOVX is a StrongBuy and STRO is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Feb 09, 2026
Stock price -- (GOVX: $2.67 vs. STRO: $15.52)
Brand notoriety: GOVX and STRO are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: GOVX: 40% vs. STRO: 91%
Market capitalization -- GOVX: $4.64M vs. STRO: $131.54M
GOVX [@Biotechnology] is valued at $4.64M. STRO’s [@Biotechnology] market capitalization is $131.54M. The market cap for tickers in the [@Biotechnology] industry ranges from $121.26B to $0. The average market capitalization across the [@Biotechnology] industry is $2.21B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

GOVX’s FA Score shows that 0 FA rating(s) are green whileSTRO’s FA Score has 0 green FA rating(s).

  • GOVX’s FA Score: 0 green, 5 red.
  • STRO’s FA Score: 0 green, 5 red.
According to our system of comparison, STRO is a better buy in the long-term than GOVX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

GOVX’s TA Score shows that 4 TA indicator(s) are bullish while STRO’s TA Score has 3 bullish TA indicator(s).

  • GOVX’s TA Score: 4 bullish, 3 bearish.
  • STRO’s TA Score: 3 bullish, 5 bearish.
According to our system of comparison, GOVX is a better buy in the short-term than STRO.

Price Growth

GOVX (@Biotechnology) experienced а -4.64% price change this week, while STRO (@Biotechnology) price change was +3.81% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -2.30%. For the same industry, the average monthly price growth was -2.98%, and the average quarterly price growth was +31.79%.

Reported Earning Dates

STRO is expected to report earnings on Mar 12, 2026.

Industries' Descriptions

@Biotechnology (-2.30% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
STRO($132M) has a higher market cap than GOVX($4.64M). STRO YTD gains are higher at: 34.140 vs. GOVX (-37.544). GOVX has higher annual earnings (EBITDA): -25.24M vs. STRO (-166.43M). STRO has more cash in the bank: 168M vs. GOVX (48.3K). GOVX has less debt than STRO: GOVX (142K) vs STRO (17.7M). STRO has higher revenues than GOVX: STRO (106M) vs GOVX (3.35M).
GOVXSTROGOVX / STRO
Capitalization4.64M132M4%
EBITDA-25.24M-166.43M15%
Gain YTD-37.54434.140-110%
P/E RatioN/AN/A-
Revenue3.35M106M3%
Total Cash48.3K168M0%
Total Debt142K17.7M1%
FUNDAMENTALS RATINGS
GOVX vs STRO: Fundamental Ratings
GOVX
STRO
OUTLOOK RATING
1..100
145
VALUATION
overvalued / fair valued / undervalued
1..100
50
Fair valued
50
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
100100
PRICE GROWTH RATING
1..100
9837
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
9090

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

GOVX's Valuation (50) in the null industry is in the same range as STRO (50) in the Pharmaceuticals Major industry. This means that GOVX’s stock grew similarly to STRO’s over the last 12 months.

GOVX's Profit vs Risk Rating (100) in the null industry is in the same range as STRO (100) in the Pharmaceuticals Major industry. This means that GOVX’s stock grew similarly to STRO’s over the last 12 months.

GOVX's SMR Rating (100) in the null industry is in the same range as STRO (100) in the Pharmaceuticals Major industry. This means that GOVX’s stock grew similarly to STRO’s over the last 12 months.

STRO's Price Growth Rating (37) in the Pharmaceuticals Major industry is somewhat better than the same rating for GOVX (98) in the null industry. This means that STRO’s stock grew somewhat faster than GOVX’s over the last 12 months.

STRO's P/E Growth Rating (100) in the Pharmaceuticals Major industry is in the same range as GOVX (100) in the null industry. This means that STRO’s stock grew similarly to GOVX’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
GOVXSTRO
RSI
ODDS (%)
Bullish Trend 3 days ago
87%
Bearish Trend 3 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 3 days ago
83%
Bearish Trend 3 days ago
90%
Momentum
ODDS (%)
Bearish Trend 3 days ago
90%
Bullish Trend 3 days ago
88%
MACD
ODDS (%)
Bullish Trend 4 days ago
88%
Bearish Trend 3 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
90%
Bullish Trend 3 days ago
80%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
90%
Bullish Trend 3 days ago
77%
Advances
ODDS (%)
N/A
Bullish Trend 7 days ago
79%
Declines
ODDS (%)
Bearish Trend 10 days ago
90%
Bearish Trend 11 days ago
88%
BollingerBands
ODDS (%)
Bullish Trend 3 days ago
90%
Bearish Trend 3 days ago
90%
Aroon
ODDS (%)
Bearish Trend 3 days ago
90%
Bullish Trend 3 days ago
77%
View a ticker or compare two or three
Interact to see
Advertisement
GOVX
Daily Signal:
Gain/Loss:
STRO
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
KBDCF4.100.75
+22.39%
Kingboard Holdings Ltd.
EGHSF13.050.01
+0.05%
Enghouse Systems Ltd.
FFBW14.86N/A
N/A
FFBW, Inc.
RSCF0.05N/A
N/A
Reflect Scientific, Inc.
SGGKY77.00N/A
N/A
Singapore Technologies Engineering Ltd.

GOVX and

Correlation & Price change

A.I.dvisor indicates that over the last year, GOVX has been closely correlated with ATOS. These tickers have moved in lockstep 76% of the time. This A.I.-generated data suggests there is a high statistical probability that if GOVX jumps, then ATOS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GOVX
1D Price
Change %
GOVX100%
+3.49%
ATOS - GOVX
76%
Closely correlated
+0.19%
STRO - GOVX
76%
Closely correlated
+6.30%
ACET - GOVX
74%
Closely correlated
+9.16%
TERN - GOVX
73%
Closely correlated
+6.88%
PMN - GOVX
73%
Closely correlated
-2.82%
More

STRO and

Correlation & Price change

A.I.dvisor indicates that over the last year, STRO has been closely correlated with TERN. These tickers have moved in lockstep 89% of the time. This A.I.-generated data suggests there is a high statistical probability that if STRO jumps, then TERN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To STRO
1D Price
Change %
STRO100%
+6.30%
TERN - STRO
89%
Closely correlated
+6.88%
ACET - STRO
89%
Closely correlated
+9.16%
ATOS - STRO
89%
Closely correlated
+0.19%
GLSI - STRO
88%
Closely correlated
+15.13%
CANF - STRO
87%
Closely correlated
-2.12%
More